Yukihiro Shimizu

2.9k total citations
66 papers, 2.3k citations indexed

About

Yukihiro Shimizu is a scholar working on Hepatology, Epidemiology and Immunology. According to data from OpenAlex, Yukihiro Shimizu has authored 66 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Hepatology, 21 papers in Epidemiology and 20 papers in Immunology. Recurrent topics in Yukihiro Shimizu's work include Liver Disease Diagnosis and Treatment (15 papers), Immune Cell Function and Interaction (14 papers) and Immunotherapy and Immune Responses (10 papers). Yukihiro Shimizu is often cited by papers focused on Liver Disease Diagnosis and Treatment (15 papers), Immune Cell Function and Interaction (14 papers) and Immunotherapy and Immune Responses (10 papers). Yukihiro Shimizu collaborates with scholars based in Japan, United States and Italy. Yukihiro Shimizu's co-authors include Kazuto Tajiri, Akiharu Watanabe, Kiyohiro Higuchi, Ryuji Suzuki, Katsuo Kumagai, Kazuko Handa, Hidetaka Matsui, Toshiro Sugiyama, Kazuhiko Okada and Masami Minemura and has published in prestigious journals such as The Journal of Immunology, Hepatology and Journal of Hepatology.

In The Last Decade

Yukihiro Shimizu

64 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yukihiro Shimizu Japan 28 972 634 514 496 412 66 2.3k
Karl-Hermann Meyer zum Büschenfelde Germany 17 869 0.9× 582 0.9× 502 1.0× 362 0.7× 328 0.8× 24 1.9k
Nobuhiro Nakamoto Japan 30 1.0k 1.0× 1.2k 1.9× 1.0k 2.0× 386 0.8× 613 1.5× 113 2.8k
Robert K. Gieseler Germany 26 685 0.7× 771 1.2× 531 1.0× 134 0.3× 376 0.9× 55 2.1k
S. Rossol Germany 30 904 0.9× 1.5k 2.3× 1.2k 2.3× 309 0.6× 798 1.9× 101 3.4k
Ludger Leifeld Germany 26 528 0.5× 810 1.3× 824 1.6× 220 0.4× 227 0.6× 73 2.1k
M Sata Japan 28 308 0.3× 868 1.4× 780 1.5× 236 0.5× 740 1.8× 124 2.8k
Zongming E. Chen United States 22 902 0.9× 613 1.0× 329 0.6× 521 1.1× 575 1.4× 34 2.5k
M.P. Manns Germany 24 256 0.3× 937 1.5× 970 1.9× 259 0.5× 297 0.7× 131 2.0k
Keisuke Hamasaki Japan 28 419 0.4× 1.3k 2.0× 1.0k 2.0× 381 0.8× 744 1.8× 66 2.6k
Linling Cheng United States 19 705 0.7× 446 0.7× 557 1.1× 200 0.4× 245 0.6× 38 1.6k

Countries citing papers authored by Yukihiro Shimizu

Since Specialization
Citations

This map shows the geographic impact of Yukihiro Shimizu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yukihiro Shimizu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yukihiro Shimizu more than expected).

Fields of papers citing papers by Yukihiro Shimizu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yukihiro Shimizu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yukihiro Shimizu. The network helps show where Yukihiro Shimizu may publish in the future.

Co-authorship network of co-authors of Yukihiro Shimizu

This figure shows the co-authorship network connecting the top 25 collaborators of Yukihiro Shimizu. A scholar is included among the top collaborators of Yukihiro Shimizu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yukihiro Shimizu. Yukihiro Shimizu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tajiri, Kazuto, Kazuhiko Okada, Hiroyuki Ito, et al.. (2023). Long term changes in thrombocytopenia and leucopenia after HCV eradication with direct-acting antivirals. BMC Gastroenterology. 23(1). 182–182.
2.
Tajiri, Kazuto, Yoshiharu Tokimitsu, Kengo Kawai, et al.. (2022). Impact of Post-progression Survival on Outcomes of Lenvatinib Treatment for Unresectable Hepatocellular Carcinoma: A Systematic Review and Retrospective Cohort Study. Anticancer Research. 42(12). 6007–6018. 3 indexed citations
3.
Tajiri, Kazuto, Yoshiharu Tokimitsu, Yoshinari Atarashi, et al.. (2018). Survival Benefit of Tolvaptan for Refractory Ascites in Patients with Advanced Cirrhosis. Digestive Diseases. 36(4). 314–321. 9 indexed citations
4.
Tajiri, Kazuto & Yukihiro Shimizu. (2017). Recent advances in the management of pruritus in chronic liver diseases. World Journal of Gastroenterology. 23(19). 3418–3418. 37 indexed citations
5.
Aoyama, Tadashi, Masashi Takano, Morikazu Miyamoto, et al.. (2017). Is there any predictor for hypersensitivity reactions in gynecologic cancer patients treated with paclitaxel-based therapy?. Cancer Chemotherapy and Pharmacology. 80(1). 65–69. 15 indexed citations
6.
Yoshikawa, Tomoyuki, Masashi Takano, Morikazu Miyamoto, et al.. (2017). Psoas muscle volume as a predictor of peripheral neurotoxicity induced by primary chemotherapy in ovarian cancers. Cancer Chemotherapy and Pharmacology. 80(3). 555–561. 26 indexed citations
7.
Tajiri, Kazuto & Yukihiro Shimizu. (2014). Immunological aspects of drug-induced liver injury. 4(3). 149–149. 2 indexed citations
8.
Shimizu, Yukihiro. (2012). T cell immunopathogenesis and immunotherapeutic strategies for chronic hepatitis B virus infection. World Journal of Gastroenterology. 18(20). 2443–2443. 41 indexed citations
9.
10.
Tajiri, Kazuto, Yukihiro Shimizu, Koichi Tsuneyama, & Toshiro Sugiyama. (2009). Role of liver-infiltrating CD3+CD56+ natural killer T cells in the pathogenesis of nonalcoholic fatty liver disease. European Journal of Gastroenterology & Hepatology. 21(6). 673–680. 102 indexed citations
11.
Tajiri, Kazuto & Yukihiro Shimizu. (2008). Practical guidelines for diagnosis and early management of drug-induced liver injury. World Journal of Gastroenterology. 14(44). 6774–6774. 139 indexed citations
12.
Shimizu, Yukihiro. (2008). Liver in systemic disease. World Journal of Gastroenterology. 14(26). 4111–4111. 53 indexed citations
13.
Tajiri, Kazuto, Yukihiro Shimizu, Koichi Tsuneyama, & Toshiro Sugiyama. (2006). A case report of oxidative stress in a patient with anorexia nervosa. International Journal of Eating Disorders. 39(7). 616–618. 31 indexed citations
14.
Atarashi, Yoshinari, Yukihiro Shimizu, Masaya Iwamoto, et al.. (2005). A domestic case of acute sporadic hepatitis E first identified in Toyama prefecture. Kanzo. 46(11). 647–652. 4 indexed citations
15.
Shimizu, Yukihiro, et al.. (2002). Phenotypic analysis of circulating and intrahepatic dendritic cell subsets in patients with chronic liver diseases. Journal of Hepatology. 36(6). 734–741. 70 indexed citations
16.
Watanabe, Akiko, Kenji Okada, Yukihiro Shimizu, et al.. (2000). Nutritional therapy of chronic hepatitis by whey protein (non-heated).. PubMed. 31(5-6). 283–302. 37 indexed citations
17.
Shimizu, Yukihiro. (2000). Immunotherapy for Unresectable or Advanced Liver Cancer. Asian Journal of Surgery. 23(1). 42–42. 1 indexed citations
18.
Shimizu, Yukihiro, Masami Minemura, Takashi Tsukishiro, et al.. (1995). Interleukin-8 produced by human hepatocellular carcinoma cell lines has an angiogenic activity.. Kanzo. 36(3). 144–150. 1 indexed citations
19.
Shimizu, Yukihiro, Masami Minemura, Takashi Tsukishiro, et al.. (1995). Serum concentration of intercellular adhesion molecule-1 in patients with hepatocellular carcinoma is a marker of the disease progression and prognosis. Hepatology. 22(2). 525–531. 48 indexed citations
20.
Shimizu, Yukihiro, Akiharu Watanabe, & Theresa L. Whiteside. (1992). Memory T-lymphocytes are the main population of tumor-infiltrating lymphocytes obtained from human primary liver tumors. Journal of Hepatology. 16(1-2). 197–202. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Karl-Hermann Meyer zum Büschenfelde Breakdown of academic impact, for papers by Nobuhiro Nakamoto Breakdown of academic impact, for papers by Robert K. Gieseler Breakdown of academic impact, for papers by S. Rossol Breakdown of academic impact, for papers by Ludger Leifeld Breakdown of academic impact, for papers by M Sata Breakdown of academic impact, for papers by Zongming E. Chen Breakdown of academic impact, for papers by M.P. Manns Breakdown of academic impact, for papers by Keisuke Hamasaki Breakdown of academic impact, for papers by Linling Cheng
Rankless by CCL
2026